BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 96 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $455,000 | +46.3% | 352,465 | +18.9% | 0.01% | +85.7% |
Q3 2019 | $311,000 | -61.9% | 296,349 | -38.3% | 0.01% | -61.1% |
Q2 2019 | $817,000 | -32.0% | 480,328 | +34.6% | 0.02% | -30.8% |
Q1 2019 | $1,202,000 | +291.5% | 356,733 | +239.8% | 0.03% | +225.0% |
Q4 2018 | $307,000 | – | 104,973 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 1,051,441 | $3,070,000 | 0.79% |
X-Square Capital, LLC | 109,832 | $321,000 | 0.25% |
KNOTT DAVID M | 111,427 | $325,000 | 0.15% |
ARK Investment Management | 1,033,491 | $3,018,000 | 0.12% |
Baker Brothers Advisors | 2,677,818 | $7,819,000 | 0.06% |
HARVEY CAPITAL MANAGEMENT INC | 31,200 | $91,000 | 0.05% |
DAFNA Capital Management LLC | 30,000 | $88,000 | 0.04% |
WASATCH ADVISORS LP | 953,368 | $2,784,000 | 0.04% |
FRANKLIN STREET ADVISORS INC /NC | 51,415 | $150,000 | 0.02% |
FARALLON CAPITAL MANAGEMENT LLC | 1,000,000 | $2,920,000 | 0.02% |